4a, b respectively); paclitaxel (PTX) alone showed a trend of improving OS (Fig. 4c ), while 6E11 alone markedly increased long-term survival rates (from 29% to 75% at 9 weeks post implantation in Fig. 4a ; from 14% to 71% at 12 weeks in Fig. 4b ).
← all excerpts
Pre- and post-operative anti-PD-L1 plus anti-angiogenic therapies in mouse breast or renal cancer models of micro- or macro-metastatic disease.
1
—
—